Role of AP-1 in Skeletal Myogenesis
Role of AP-1 in Skeletal Myogenesis
批准号:
RGPIN-2018-05896
负责人:
Mcdermott, John
金额:
$2.62万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-01-01 至 2020-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Development, maintenance and regeneration of skeletal muscle is a primal feature of eumetazoans (all animals except sponges and placozoans). Muscles, as tissues specialized for contraction, are essential effectors of the nervous system underlying activities such as locomotion, escape, feeding, and defence. In previous work we implicated the AP-1 transcription complex in the control of skeletal muscle gene regulation during the fundamental process of myogenic differentiation. Recently, we reported that AP-1 is expressed not only in embryonic myoblasts but also in the resident stem cells (satellite cells) in adult skeletal muscle, We also documented that ERK signalling stabilizes the Fra2 subunit of the AP-1 complex. Satellite cells are crucial for the vital post-natal maintenance and repair of skeletal muscle in all mammals. In the proposed studies we plan to further assess the requirement for AP-1 in skeletal muscle development and regeneration. To do this we will address the following specific hypothesis driven objectives:******1) AP-1 is required for Notch signalling in myoblasts and satellite cells.***2) Conditional cjun/fosl2 deletion in mice will disrupt embryonic myogenesis and/or post-natal muscle regeneration.***3) Growth factor signaling controls Fra2 transcription complex composition and myogenesis.******Experimental Strategy:***Objective 1: Previous work identified that AP-1 transcriptionally targets a number of components of the Notch signaling pathway in muscle. The next step is to employ gain and loss of function analysis of AP1 to assess how this influences components and downstream targets of Notch signalling in primary myoblast and single muscle fiber cultures. We will utilize traditional biochemistry and state of the art confocal live cell imaging technology to address this aim.***Objective 2: Conditional Cre-lox mediated excision of Floxed cJun and Fra2 in mice is an ambitious goal to assess the role of AP-1 in embryonic muscle formation and also post-natal muscle maintenance and regeneration.***Objective 3: Characterization of the signalling pathway regulated control of Fra2 complex composition and stability will be carried out using an innovative state of the art interactome analysis pipeline that we have developed using affinity purification-mass spectrometry, along with antibody mediated detection of post-translational modification of Fra2.******Feasibility and Impact: ***This proposal, based on extensive data generated over several NSERC funding cycles, will address the fundamental regulation of AP-1 and its role in skeletal muscle. Personnel, reagents and technology are in place to address these objectives with high feasibility. These studies will result in impactful science in line with our other contributions in this field.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
HTG-AP 患者健康行为依从性预测模型及移动健康管理模式的构建与实证研究
-
批准号:2026JJ81374
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨宏
-
依托单位:
AP4M1通过USP15去泛素化作用抑制铁死亡促进肝癌进展的机制研究
-
批准号:2026JJ50091
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:周扬莹
-
依托单位:
Al@AP微单元复合体系燃烧机理及模型预示研究
-
批准号:JCZRLH202601568
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
雌激素通过AP-1靶向调控TASK-1双孔钾通道参与阿尔茨海默病神经保护的机制研究
-
批准号:JCZRLH202601678
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于抑制AP-1信号增强胆管癌光动力治疗并逆转免疫抑制微环境的分子机制与靶向干预研究
-
批准号:JCZRQN202500115
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
FTO/AP-2α-m6A/LITAF反馈环路调控子痫前期滋养细胞迁移和侵袭的作用和机制研究
-
批准号:2025JJ50721
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李瑞珍
-
依托单位:
脑胶质瘤抑瘤基因LRRC4促进含AP2A1的高尔基体网格囊泡释放调控线粒体嵴结构与氧化磷酸化影响胶质母细胞瘤生长和侵袭的机制研究
-
批准号:2025JJ60498
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李洋
-
依托单位:
Ap-Exo III 联合模式识别构建降尿酸药
物筛选新方法的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:刘利红
-
依托单位:
新融合基因AP1B1-EWSR1促进骨肉瘤发生发展的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:吕杨帆
-
依托单位:
AP-1激活miR-22/miR-210反馈调控文昌鱼JNK通路先天免疫响应的机制研究
-
批准号:QN25C040003
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:曹云鹏
-
依托单位: